Efficacy of Acupuncture in Patients With Acute Intracranial Hemorrhage
Launched by CHANG GUNG MEMORIAL HOSPITAL · Jan 28, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how acupuncture might help people recover better after experiencing an acute intracranial hemorrhage, which is a type of stroke caused by bleeding in the brain. The researchers want to find out if acupuncture can improve patients' ability to function after this medical event. The trial is currently recruiting participants aged between 20 and 85 years who have been diagnosed with a hemorrhagic stroke and have a specific level of consciousness.
To be eligible for the trial, participants must be diagnosed by a specialist and meet certain criteria, excluding those with conditions like tumors or other neurological issues that could interfere with the results. If someone joins the study, they can expect to receive acupuncture treatments and be monitored to see how well they recover. It's important for potential participants and their families to understand that this study aims to explore a non-traditional treatment approach to aid recovery after a serious health event.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of hemorrhagic stroke by a specialist
- • Age over 20 years and below 85 years
- • GCS between 5-13
- Exclusion Criteria:
- • Intracranial hemorrhage resulted from vascular anomalies
- • Pregnant patients
- • Intracranial tumor related hemorrhage
- • Other diseases that can cause neurological deficits, such as old cerebrovascular disease, poliomyelitis, cerebral palsy, spinal cord injury
- • Organ damage or terminal illness (heart or kidney failure or malignancy)
About Chang Gung Memorial Hospital
Chang Gung Memorial Hospital, one of the largest healthcare organizations in Taiwan, is renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct innovative research across various medical disciplines. With a focus on collaboration and ethical practices, Chang Gung Memorial Hospital aims to contribute to the global body of medical knowledge through rigorous clinical trials that enhance treatment options and improve health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Keelung, , Taiwan
Patients applied
Trial Officials
Yan Ru Ko
Study Director
Chang Gung Memorial Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported